Gossamer Bio, Inc.
Filings
| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2026-09-049/4/26 | New | $25,000,000 | $25,000,000 | Other | 06b | SEC linkSEC |
| 2023-08-078/7/23 | New | $212,102,057 | $212,102,057 | Equity Only | 06b | SEC linkSEC |
| 2022-07-187/18/22 | New | $120,041,922 | $120,041,922 | Equity Only | 06b | SEC linkSEC |
| 2018-08-018/1/18 | New | $230,015,000 | $230,015,000 | Equity Only | 06b | SEC linkSEC |
| 2018-01-191/19/18 | New | $70,468,084 | $70,468,084 | Equity Only | 06b | SEC linkSEC |
| 2018-01-191/19/18 | New | $70,468,084 | $70,468,084 | Equity Only | 06b | SEC linkSEC |
Directors and Executives (Current and Past)
| Name | Role |
|---|---|
| Richard Aranda, M.D. | Executive |
| Joshua Bilenker, M.D. | Director |
| Kristina Burow | Director |
| Laura Carter, Ph.D. | Executive |
| Russell Cox | Director |
| Thomas Daniel | Director |
| Thomas Daniel, M.D. | Director |
| Skye J. Drynan | Director |
| Renee Gala | Director |
| Bryan Giraudo | Executive |
| Sheila Gujrathi, M.D. | Director, Executive |
| Faheem Hasnain | Director, Executive |
| Jill Howe | Executive |
| Richard Lim | Director |
| Sandra Milligan | Director |
| Sandra Milligan, M.D., J.D. | Director |
| Steven D. Nathan | Director |
| Robert Nelsen | Director |
| Caryn Peterson | Executive |
| John Quisel | Director |
| Robert Smith | Executive |
| Otello Stampacchia, Ph.D. | Director |
| Christian Waage | Executive |
| Michael Yi | Director |
Industry: Biotechnology (See others in industry)
Address:
3115 Merryfield Row, Suite 120
San Diego, CA, 92121
Phone: (858) 684-1300
San Diego, CA, 92121
Phone: (858) 684-1300